Dermatopathology Reference Laboratory is categorized under Medical Labs in Lexington, KY and active since 1991.
Dermatopathology Reference Laboratory was established in 1991, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Fernando De Castro at the company’s single location by writing to 250 Fountain Court, Lexington, Kentucky KY 40509 or by phoning (859) 253-9365. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dermatopathology Reference Laboratory |
| Contact Person: | Fernando De Castro |
| Address: | 250 Fountain Court, Lexington, Kentucky 40509 |
| Phone Number: | (859) 253-9365 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Dermatopathology Reference Laboratory was started in 1991 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Fernando De Castro for inquiries that concern Dermatopathology Reference Laboratory by calling the company number (859) 253-9365, as your correspondence is most welcome. Additionally, the physical location of the single location of Dermatopathology Reference Laboratory can be found at the coordinates 38.00495,-84.437687 as well as the street address 250 Fountain Court in Lexington, Kentucky 40509.
For its online presence, you may visit Dermatopathology Reference Laboratory’s website at and engage with its social media outlets through on Twitter and on Facebook.